<p>(<b>A</b>) MCF7 cells were treated with increasing concentrations of PCI-24781 for 72 hours and western blotted. MCF7 cells were treated for 72 hours with vehicle (V), 0.1 µM PCI-24781 (P), 10 µM OH-tamoxifen (T), or the combination (PT) and cells extracts were evaluated by western blot (<b>B</b>) for Pan-Akt and active Akt (P<sup>S473</sup>) expression or (<b>E</b>) Akt activity <i>in vitro</i> by immunoprecipitating and then incubating phospho-Akt with a GSK-3 substrate and measuring levels of phosphorylated GSK-3. (<b>C</b>) The indicated cell lines were treated with vehicle (V) or 0.1 µM PCI-24781 and 10 µM OH-tamoxifen (PT) for 72 hours and western blotted for active Akt. (<b>D</b>) In cell extracts, levels of Akt isoforms, active A...
Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer. Activa...
<div><p>Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer...
<p>MCF-7 cells were transfected with control (siNEG) or anti-OGT siRNA (siOGT, sequence: TGGCATCGACC...
<p>MCF7 cells were transfected with 1 µM scramble, AKT1, AKT2, or AKT1 and 2 directed siRNA for (<b>...
<p>(<b>A</b>) Basal levels of AKT1, 2, and 3 mRNA in MCF7 cells are presented relative to AKT1 expre...
<p>(<b>A</b>) MCF7 cells were treated with vehicle (V), 0.1 µM PCI-24781 (P), 10 µM OH-tamoxifen (T)...
<p>A. C6 glioma cells were treated with combined LY294002 (20 µmol/L) and tamoxifen (5 µmol/L) for i...
<p>C6 glioma cells were treated with PI3K inhibitor LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM,...
The tamoxifen-resistant (TAM-R) MCF-7 breast cancer cell line has been used as a model to identify t...
<p>Hec1A cells were treated with 10 nM E2 (A) or 2 µM Tam (B) for the indicated time points and the ...
Tamoxifen is an effective anti-estrogen for treatment of women with hormonedependent breast cancer b...
<p>(A) Representative blot of time dependent effect of 15 µM PEITC on p-EGFR (Tyr 1068), p-AKT (Ser-...
<p>MCF-7 cells were cultured in presence of 1% FBS during 24 hours in the absence or presence PUGNAc...
<p>C6 glioma cells were treated with LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM, 5 µmol/L) for ...
<p>(A) Western blot analysis of MCF-7 cells was performed following 24-hour treatment with either Ta...
Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer. Activa...
<div><p>Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer...
<p>MCF-7 cells were transfected with control (siNEG) or anti-OGT siRNA (siOGT, sequence: TGGCATCGACC...
<p>MCF7 cells were transfected with 1 µM scramble, AKT1, AKT2, or AKT1 and 2 directed siRNA for (<b>...
<p>(<b>A</b>) Basal levels of AKT1, 2, and 3 mRNA in MCF7 cells are presented relative to AKT1 expre...
<p>(<b>A</b>) MCF7 cells were treated with vehicle (V), 0.1 µM PCI-24781 (P), 10 µM OH-tamoxifen (T)...
<p>A. C6 glioma cells were treated with combined LY294002 (20 µmol/L) and tamoxifen (5 µmol/L) for i...
<p>C6 glioma cells were treated with PI3K inhibitor LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM,...
The tamoxifen-resistant (TAM-R) MCF-7 breast cancer cell line has been used as a model to identify t...
<p>Hec1A cells were treated with 10 nM E2 (A) or 2 µM Tam (B) for the indicated time points and the ...
Tamoxifen is an effective anti-estrogen for treatment of women with hormonedependent breast cancer b...
<p>(A) Representative blot of time dependent effect of 15 µM PEITC on p-EGFR (Tyr 1068), p-AKT (Ser-...
<p>MCF-7 cells were cultured in presence of 1% FBS during 24 hours in the absence or presence PUGNAc...
<p>C6 glioma cells were treated with LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM, 5 µmol/L) for ...
<p>(A) Western blot analysis of MCF-7 cells was performed following 24-hour treatment with either Ta...
Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer. Activa...
<div><p>Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer...
<p>MCF-7 cells were transfected with control (siNEG) or anti-OGT siRNA (siOGT, sequence: TGGCATCGACC...